EMEA (Europe, Middle East and Africa) Opioid Antagonist Drug Market Report 2017

December 2017 | 101 pages | ID: EB60AD7A1B0EN
QYResearch

Abstracts

In this report, the EMEA Opioid Antagonist Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Opioid Antagonist Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Opioid Antagonist Drug market competition by top manufacturers/players, with Opioid Antagonist Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Conatus Pharmaceuticals
• Novartis
• Intercept Pharmaceuticals
• Allergan
• Immuron
• Takeda
• Gilead Sciences
• Genfit

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Tablet
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Opioid Antagonist Drug Market Report 2017

1 OPIOID ANTAGONIST DRUG OVERVIEW

1.1 Product Overview and Scope of Opioid Antagonist Drug
1.2 Classification of Opioid Antagonist Drug
  1.2.1 EMEA Opioid Antagonist Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Opioid Antagonist Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Injection
1.3 EMEA Opioid Antagonist Drug Market by Application/End Users
  1.3.1 EMEA Opioid Antagonist Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Medical Center
1.4 EMEA Opioid Antagonist Drug Market by Region
  1.4.1 EMEA Opioid Antagonist Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Opioid Antagonist Drug (2012-2022)
  1.5.1 EMEA Opioid Antagonist Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Opioid Antagonist Drug Revenue and Growth Rate (2012-2022)

2 EMEA OPIOID ANTAGONIST DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Opioid Antagonist Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Opioid Antagonist Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Opioid Antagonist Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Opioid Antagonist Drug Sale Price by Players (2012-2017)
2.2 EMEA Opioid Antagonist Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Opioid Antagonist Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Opioid Antagonist Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Opioid Antagonist Drug Sale Price by Type (2012-2017)
2.3 EMEA Opioid Antagonist Drug (Volume) by Application
2.4 EMEA Opioid Antagonist Drug (Volume and Value) by Region
  2.4.1 EMEA Opioid Antagonist Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Opioid Antagonist Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Opioid Antagonist Drug Sales Price by Region (2012-2017)

3 EUROPE OPIOID ANTAGONIST DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Opioid Antagonist Drug Sales and Value (2012-2017)
  3.1.1 Europe Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Opioid Antagonist Drug Sales and Market Share by Type
3.3 Europe Opioid Antagonist Drug Sales and Market Share by Application
3.4 Europe Opioid Antagonist Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Opioid Antagonist Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Opioid Antagonist Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Opioid Antagonist Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OPIOID ANTAGONIST DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Opioid Antagonist Drug Sales and Value (2012-2017)
  4.1.1 Middle East Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Opioid Antagonist Drug Sales and Market Share by Type
4.3 Middle East Opioid Antagonist Drug Sales and Market Share by Application
4.4 Middle East Opioid Antagonist Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Opioid Antagonist Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Opioid Antagonist Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Opioid Antagonist Drug Sales and Growth Rate (2012-2017)

5 AFRICA OPIOID ANTAGONIST DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Opioid Antagonist Drug Sales and Value (2012-2017)
  5.1.1 Africa Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Opioid Antagonist Drug Sales and Market Share by Type
5.3 Africa Opioid Antagonist Drug Sales and Market Share by Application
5.4 Africa Opioid Antagonist Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Opioid Antagonist Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Opioid Antagonist Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Opioid Antagonist Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Opioid Antagonist Drug Sales and Growth Rate (2012-2017)

6 EMEA OPIOID ANTAGONIST DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Conatus Pharmaceuticals
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Conatus Pharmaceuticals Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Intercept Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Intercept Pharmaceuticals Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Allergan
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Allergan Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Immuron
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Immuron Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Takeda
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Takeda Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Gilead Sciences
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Gilead Sciences Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Genfit
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Opioid Antagonist Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Genfit Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 OPIOID ANTAGONIST DRUG MANUFACTURING COST ANALYSIS

7.1 Opioid Antagonist Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioid Antagonist Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Opioid Antagonist Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioid Antagonist Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OPIOID ANTAGONIST DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Opioid Antagonist Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Opioid Antagonist Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Opioid Antagonist Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Opioid Antagonist Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Opioid Antagonist Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Opioid Antagonist Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Opioid Antagonist Drug
Figure EMEA Opioid Antagonist Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Opioid Antagonist Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Injection Product Picture
Figure EMEA Opioid Antagonist Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Opioid Antagonist Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure EMEA Opioid Antagonist Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Opioid Antagonist Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Opioid Antagonist Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Opioid Antagonist Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Opioid Antagonist Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Opioid Antagonist Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Opioid Antagonist Drug Sales Share by Players (2012-2017)
Figure 2016 Opioid Antagonist Drug Sales Share by Players
Figure 2017 Opioid Antagonist Drug Sales Share by Players
Figure EMEA Opioid Antagonist Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Opioid Antagonist Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Opioid Antagonist Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Opioid Antagonist Drug Revenue Share by Players
Table 2017 EMEA Opioid Antagonist Drug Revenue Share by Players
Table EMEA Opioid Antagonist Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Opioid Antagonist Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Opioid Antagonist Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Opioid Antagonist Drug by Type (2012-2017)
Figure EMEA Opioid Antagonist Drug Sales Market Share by Type (2012-2017)
Table EMEA Opioid Antagonist Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Opioid Antagonist Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Opioid Antagonist Drug by Type in 2016
Table EMEA Opioid Antagonist Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Opioid Antagonist Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Opioid Antagonist Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Opioid Antagonist Drug by Application (2012-2017)
Figure EMEA Opioid Antagonist Drug Sales Market Share by Application in 2016
Table EMEA Opioid Antagonist Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Opioid Antagonist Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Opioid Antagonist Drug by Region (2012-2017)
Figure EMEA Opioid Antagonist Drug Sales Market Share in 2016
Table EMEA Opioid Antagonist Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Opioid Antagonist Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Opioid Antagonist Drug by Region (2012-2017)
Figure EMEA Opioid Antagonist Drug Revenue Market Share Regions in 2016
Table EMEA Opioid Antagonist Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
Table Europe Opioid Antagonist Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Opioid Antagonist Drug Market Share by Type (2012-2017)
Figure Europe Opioid Antagonist Drug Market Share by Type in 2016
Table Europe Opioid Antagonist Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Opioid Antagonist Drug Market Share by Application (2012-2017)
Figure Europe Opioid Antagonist Drug Market Share by Application in 2016
Table Europe Opioid Antagonist Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Opioid Antagonist Drug Sales Market Share by Countries (2012-2017)
Figure Europe Opioid Antagonist Drug Sales Market Share by Countries (2012-2017)
Figure Europe Opioid Antagonist Drug Sales Market Share by Countries in 2016
Table Europe Opioid Antagonist Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Opioid Antagonist Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Opioid Antagonist Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Opioid Antagonist Drug Revenue Market Share by Countries in 2016
Figure Germany Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Opioid Antagonist Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Opioid Antagonist Drug Market Share by Type (2012-2017)
Figure Middle East Opioid Antagonist Drug Market Share by Type (2012-2017)
Table Middle East Opioid Antagonist Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Opioid Antagonist Drug Market Share by Applications (2012-2017)
Figure Middle East Opioid Antagonist Drug Sales Market Share by Application in 2016
Table Middle East Opioid Antagonist Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Opioid Antagonist Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Opioid Antagonist Drug Sales Volume Market Share by Countries in 2016
Table Middle East Opioid Antagonist Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Opioid Antagonist Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Opioid Antagonist Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Opioid Antagonist Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Opioid Antagonist Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Opioid Antagonist Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Opioid Antagonist Drug Sales Market Share by Type (2012-2017)
Figure Africa Opioid Antagonist Drug Sales Market Share by Type (2012-2017)
Figure Africa Opioid Antagonist Drug Sales Market Share by Type in 2016
Table Africa Opioid Antagonist Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Opioid Antagonist Drug Sales Market Share by Application (2012-2017)
Figure Africa Opioid Antagonist Drug Sales Market Share by Application (2012-2017)
Table Africa Opioid Antagonist Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Opioid Antagonist Drug Sales Market Share by Countries (2012-2017)
Figure Africa Opioid Antagonist Drug Sales Market Share by Countries (2012-2017)
Figure Africa Opioid Antagonist Drug Sales Market Share by Countries in 2016
Table Africa Opioid Antagonist Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Opioid Antagonist Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Opioid Antagonist Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Opioid Antagonist Drug Revenue Market Share by Countries in 2016
Figure South Africa Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Pfizer Opioid Antagonist Drug Basic Information List
Table Pfizer Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Pfizer Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Conatus Pharmaceuticals Opioid Antagonist Drug Basic Information List
Table Conatus Pharmaceuticals Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Conatus Pharmaceuticals Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Conatus Pharmaceuticals Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Conatus Pharmaceuticals Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Novartis Opioid Antagonist Drug Basic Information List
Table Novartis Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Novartis Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Intercept Pharmaceuticals Opioid Antagonist Drug Basic Information List
Table Intercept Pharmaceuticals Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Intercept Pharmaceuticals Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Intercept Pharmaceuticals Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Intercept Pharmaceuticals Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Allergan Opioid Antagonist Drug Basic Information List
Table Allergan Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Allergan Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Immuron Opioid Antagonist Drug Basic Information List
Table Immuron Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immuron Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immuron Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Immuron Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Takeda Opioid Antagonist Drug Basic Information List
Table Takeda Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Takeda Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Takeda Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Gilead Sciences Opioid Antagonist Drug Basic Information List
Table Gilead Sciences Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gilead Sciences Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Gilead Sciences Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Gilead Sciences Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Genfit Opioid Antagonist Drug Basic Information List
Table Genfit Opioid Antagonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genfit Opioid Antagonist Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genfit Opioid Antagonist Drug Sales Market Share in EMEA (2012-2017)
Figure Genfit Opioid Antagonist Drug Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Antagonist Drug
Figure Manufacturing Process Analysis of Opioid Antagonist Drug
Figure Opioid Antagonist Drug Industrial Chain Analysis
Table Raw Materials Sources of Opioid Antagonist Drug Major Manufacturers in 2016
Table Major Buyers of Opioid Antagonist Drug
Table Distributors/Traders List
Figure EMEA Opioid Antagonist Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Opioid Antagonist Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Opioid Antagonist Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Opioid Antagonist Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Opioid Antagonist Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Opioid Antagonist Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Opioid Antagonist Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Opioid Antagonist Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Opioid Antagonist Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Opioid Antagonist Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Opioid Antagonist Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Opioid Antagonist Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Opioid Antagonist Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Opioid Antagonist Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Opioid Antagonist Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Opioid Antagonist Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Opioid Antagonist Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Opioid Antagonist Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Opioid Antagonist Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Opioid Antagonist Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Opioid Antagonist Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Opioid Antagonist Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Opioid Antagonist Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources